Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic Acid and Omega-3 in MS Cognitive Impairment
NCT02133664Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jun 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, omega-3 fatty acid in multiple sclerosis (MS), sponsored by Oregon Health & Science University. Started Jun 2014; status: completed.
02
Drugs
alpha-lipoic acidomega-3 fatty acid
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02133664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133664.